Louisiana State Employees Retirement System Arcus Biosciences, Inc. Transaction History
Louisiana State Employees Retirement System
- $5.54 Billion
- Q4 2025
A detailed history of Louisiana State Employees Retirement System transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 39,100 shares of RCUS stock, worth $784,737. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,100
Previous 31,800
22.96%
Holding current value
$784,737
Previous $432,000
81.48%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding RCUS
# of Institutions
211Shares Held
67.5MCall Options Held
3.3MPut Options Held
146K-
Black Rock Inc. New York, NY9.76MShares$196 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.63MShares$133 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.33MShares$87 Million0.12% of portfolio
-
Woodline Partners LP San Francisco, CA3.77MShares$75.7 Million0.26% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$74 Million1.51% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.45B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...